Archive of Author | Tom Robinson

Dr. Tom Robinson obtained his first degree in Physics at Imperial College London. After wanting to broaden his scientific interests but still utilised his background in Physics, he completed an interdisciplinary PhD between Chemistry, Physics and Biology also at Imperial College. Here he specialised in Microfluidic Technology and Advanced Microscopy with the application of improving the detection of enzyme-DNA binding. After which he spent 3 years as a Postdoc at ETH Zurich continuing his passion for microfluidics, but also being introduced to biomimetic lipid membrane vesicles. His last postdoc position was at the Max Planck Institute for Colloids and Interfaces in Potsdam working on synthetic lipid membrane fusion systems, and since early 2016 has been an independent research group leader funded via the MaxSynBio network. Now his group continues to develop novel microfluidic platforms and work on bottom-up synthetic biology applications.

Articles with Tom Robinson


Aesthetics get Synthetic: Knowledge Link through Art and Science – Tom Robinson

Aesthetics get Synthetic: Knowledge Link through Art and Science (KLAS) is an Artist in Residence program of the Max Planck Society. The innovative artist residency program brought professional artists into high-quality research groups and, by doing so, established a bridge between art, science and society. Knowledge Link through Art & Science (KLAS) fosters ArtSci exchanges and trans/disciplinary innovation and education whilst also creating a link between Synthetic Biology research groups in leading institutions.

Dr. Tom Robinson obtained his first degree in Physics at Imperial College London. After wanting to broaden his scientific interests but still utilised his background in Physics, he completed an interdisciplinary PhD between Chemistry, Physics and Biology. His last postdoc position was at the Max Planck Institute for Colloids and Interfaces in Potsdam, and since early 2016 has been an independent research group leader funded via the MaxSynBio network.